Literature DB >> 17055458

MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.

Jung-Hee Kang1, Piotr G Rychahou, Titilope A Ishola, Jingbo Qiao, B Mark Evers, Dai H Chung.   

Abstract

MYCN amplification strongly correlates with unfavorable outcomes in patients with neuroblastoma. The aim of this study was to investigate the role of MYCN in neuroblastoma cell differentiation and apoptosis. We used the technique of RNA interference to inhibit MYCN gene expression in neuroblastoma cells with variable expression of MYCN. Our results showed that inhibition of MYCN gene expression in MYCN amplified cells induced apoptosis and suppressed cell growth; neuronal differentiation also occurred after MYCN gene silencing. Moreover, N-myc downregulation was associated with decreased Bcl-xL protein levels and caspase-3 activation. These data show that small interfering RNA directed to MYCN, which plays a crucial role in neuroblastoma cell survival, may provide a potential novel therapeutic option for aggressive neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055458      PMCID: PMC2708968          DOI: 10.1016/j.bbrc.2006.10.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product.

Authors:  U Galderisi; G Di Bernardo; M Cipollaro; G Peluso; A Cascino; R Cotrufo; M A Melone
Journal:  J Cell Biochem       Date:  1999-04-01       Impact factor: 4.429

Review 2.  RNAi-mediated pathways in the nucleus.

Authors:  Marjori A Matzke; James A Birchler
Journal:  Nat Rev Genet       Date:  2005-01       Impact factor: 53.242

3.  Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line.

Authors:  A Negroni; S Scarpa; A Romeo; S Ferrari; A Modesti; G Raschellà
Journal:  Cell Growth Differ       Date:  1991-10

4.  Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines.

Authors:  L Whitesell; A Rosolen; L M Neckers
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

5.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

6.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis.

Authors:  Y T Hsu; K G Wolter; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Characteristics of stem cells from human neuroblastoma cell lines and in tumors.

Authors:  Jeanette D Walton; David R Kattan; Sharon K Thomas; Barbara A Spengler; Hong-Fen Guo; June L Biedler; Nai-Kong V Cheung; Robert A Ross
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

8.  Targeted expression of MYCN causes neuroblastoma in transgenic mice.

Authors:  W A Weiss; K Aldape; G Mohapatra; B G Feuerstein; J M Bishop
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

9.  Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

10.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

View more
  65 in total

1.  Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.

Authors:  Pritha Paul; Lauren A Gillory; JungHee Kang; Jingbo Qiao; Dai H Chung
Journal:  Surgery       Date:  2010-10-29       Impact factor: 3.982

2.  Closing the phenotypic gap between transformed neuronal cell lines in culture and untransformed neurons.

Authors:  Tereance A Myers; Cheryl A Nickerson; Deepak Kaushal; C Mark Ott; Kerstin Höner zu Bentrup; Rajee Ramamurthy; Mayra Nelman-Gonzalez; Duane L Pierson; Mario T Philipp
Journal:  J Neurosci Methods       Date:  2008-07-10       Impact factor: 2.390

3.  Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation.

Authors:  Sora Lee; Brian T Craig; Carmelle V Romain; Jingbo Qiao; Dai H Chung
Journal:  Cancer Lett       Date:  2014-09-28       Impact factor: 8.679

Review 4.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

5.  MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid.

Authors:  Ruhina Maeshima; Dale Moulding; Andrew W Stoker; Stephen L Hart
Journal:  Nucleic Acid Ther       Date:  2020-04-02       Impact factor: 5.486

6.  Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.

Authors:  Yuan Li; Baofu Zhang; Hongwei Zhang; Xiaoyu Zhu; Dongchuan Feng; Deyong Zhang; Baobiao Zhuo; Liantao Li; Junnian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

7.  Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.

Authors:  Rhamy Zeid; Matthew A Lawlor; Evon Poon; Jaime M Reyes; Mariateresa Fulciniti; Michael A Lopez; Thomas G Scott; Behnam Nabet; Michael A Erb; Georg E Winter; Zoe Jacobson; Donald R Polaski; Kristen L Karlin; Rachel A Hirsch; Nikhil P Munshi; Thomas F Westbrook; Louis Chesler; Charles Y Lin; James E Bradner
Journal:  Nat Genet       Date:  2018-01-29       Impact factor: 38.330

8.  N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Authors:  J Kang; P G Rychahou; T A Ishola; J M Mourot; B M Evers; D H Chung
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

9.  FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.

Authors:  Michael L Megison; Jerry E Stewart; Hugh C Nabers; Lauren A Gillory; Elizabeth A Beierle
Journal:  Clin Exp Metastasis       Date:  2012-12-04       Impact factor: 5.150

10.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.